Literature DB >> 5361911

[Synthesis of salmon calcitonin, a high activity hypocalcemic hormone].

S Guttmann, J Pless, R L Huguenin, E Sandrin, H Bossert, K Zehnder.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 5361911     DOI： 10.1002/hlca.19690520702

Source DB:  PubMed          Journal:  Helv Chim Acta        ISSN： 0018-019X            Impact factor:   2.164


× No keyword cloud information.
  6 in total

1.  Competitive binding of antibodies and antigen-antibody complexes to receptors on spleen lymphocytes.

Authors:  W Niederer
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

2.  Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.

Authors:  M Azria; C Behhar; S Cooper
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

3.  25 years of salmon calcitonin: from synthesis to therapeutic use.

Authors:  M Azria; D H Copp; J M Zanelli
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

4.  Synthesis of eel-calcitonin and (asu1,7)-eel-calcitonin: contribution of the disulfide bond to the hormonal activity.

Authors:  T Morikawa; E Munekata; S Sakakibara; T Noda; M Otani
Journal:  Experientia       Date:  1976-09-15

5.  Renal effects of calcitonin and parathyroid extract in man. Studies in hypoparathyroidism.

Authors:  H G Haas; M A Dambacher; J Guncaga; T Lauffenbruger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

6.  Treatment of Paget's disease of bone with synthetic salmon calcitonin.

Authors:  J A Kanis; D B Horn; R D Scott; J A Strong
Journal:  Br Med J       Date:  1974-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.